Schmidt-Erfurth U - Search Results

1

Antivascular endothelial growth factors in age-related macular degeneration.

Schmidt-Erfurth U, Pollreisz A, Mitsch C, Bolz M. Schmidt-Erfurth U, et al. Dev Ophthalmol. 2010;46:21-38. doi: 10.1159/000320007. Epub 2010 Aug 10. Dev Ophthalmol. 2010. PMID: 20703030

2

Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration.

Ergun E, Maár N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Ergun E, et al. Ophthalmology. 2003 Jan;110(1):65-9. doi: 10.1016/s0161-6420(02)01566-x. Ophthalmology. 2003. PMID: 12511348 Clinical Trial.

3

Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Schmidt-Erfurth U, Michels S, Michels R, Aue A. Schmidt-Erfurth U, et al. Eur J Ophthalmol. 2005 Jul-Aug;15(4):482-5. doi: 10.1177/112067210501500411. Eur J Ophthalmol. 2005. PMID: 16001382 Clinical Trial.

4

Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.

Michels S, Wachtlin J, Gamulescu MA, Heimann H, Prünte C, Inhoffen W, Krebs I, Schmidt-Erfurth U. Michels S, et al. Ophthalmology. 2005 Dec;112(12):2070-5. doi: 10.1016/j.ophtha.2005.06.034. Epub 2005 Oct 12. Ophthalmology. 2005. PMID: 16225928 Clinical Trial.

5

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U. Augustin AJ, et al. Ophthalmology. 2006 Jan;113(1):14-22. doi: 10.1016/j.ophtha.2005.09.002. Epub 2005 Dec 19. Ophthalmology. 2006. PMID: 16360209

6

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U. Augustin AJ, et al. Am J Ophthalmol. 2006 Apr;141(4):638-45. doi: 10.1016/j.ajo.2005.11.058. Am J Ophthalmol. 2006. PMID: 16564797

7

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Bolz M, Michels S, Geitzenauer W, Prager F, Schmidt-Erfurth U. Bolz M, et al. Br J Ophthalmol. 2007 Jun;91(6):785-9. doi: 10.1136/bjo.2006.102467. Epub 2006 Oct 18. Br J Ophthalmol. 2007. PMID: 17050580 Free PMC article. Clinical Trial.

8

Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U. Augustin AJ, et al. Eur J Ophthalmol. 2006 Nov-Dec;16(6):824-34. doi: 10.1177/112067210601600607. Eur J Ophthalmol. 2006. PMID: 17191188 Review.

9

Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U. Stifter E, et al. Am J Ophthalmol. 2007 Dec;144(6):886-892. doi: 10.1016/j.ajo.2007.07.034. Epub 2007 Oct 4. Am J Ophthalmol. 2007. PMID: 17916314

10

Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degeneration.

Schmidt-Erfurth U, Sacu S; Early Retreatment Study Group. Schmidt-Erfurth U, et al. Ophthalmology. 2008 Jan;115(1):134-40. doi: 10.1016/j.ophtha.2007.02.033. Ophthalmology. 2008. PMID: 18166408 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters